LB Pharmaceuticals

tenant

drug

Various Screening psychiatric and medical assessments

as of 2026-07-01

Add to landscape Monitor this Compare this Ask about this

at a glance

BEHAVIORAL

Pre-approval / investigational in the US

Developed by University of Maryland, Baltimore County

1 trials in the graph

Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality

BEHAVIORAL

Indications

Investigational (via trials)

Schizophrenia Substance-Related Disorders Tobacco Use Disorder Marijuana Abuse Substance Abuse Cocaine-Related Disorders Schizophrenia Tobacco Use Disorder Cocaine Abuse Smoking

Trials

1

Screening Protocol for Research Participants

NCT01010620—Completed

KOLs & investigators

1

Deanna L. Kelly, Pharm.D., BCPPKOL score 5

Facts & assertions

0 sourced

No assertions recorded for this entity.

relationships

The graph out of here

developer

University of Maryland, Baltimore County

company

trial

Screening Protocol for Research Participants

trial

indication

indication

Substance-Related Disorders

indication

Tobacco Use Disorder

indication

Marijuana Abuse

indication

KOL

Deanna L. Kelly, Pharm.D., BCPP

KOL score 5

person